Literature DB >> 9717602

Ischaemic preconditioning: mechanisms and potential clinical applications.

A Hawaleshka1, E Jacobsohn.   

Abstract

PURPOSE: Brief ischaemic episodes, followed by periods of reperfusion, increase the resistance to further ischaemic damage. This response is called "ischaemic preconditioning." By reviewing the molecular basis and fundamental principals of ischaemic preconditioning, this paper will enable the anaesthetic and critical care practitioner to understand this developing therapeutic modality. SOURCE: Articles were obtained from a Medline review (1960-1997; search terms: ischaemia, reperfusion injury, preconditioning, ischaemic preconditioning, cardiac protection). Other sources include review articles, textbooks, hand-searches (Index Medicus), and personal files. PRINCIPLE FINDING: Ischaemic preconditioning is a powerful protective mechanism against ischaemic injury that has been shown to occur in a variety of organ systems, including the heart, brain, spinal cord, retina, liver, lung and skeletal muscle. Ischaemic preconditioning has both immediate and delayed protective effects, the importance of which varies between species and organ systems. While the exact mechanisms of both protective components are yet to be clearly defined, ischaemic preconditioning is a multifactorial process requiring the interaction of numerous signals, second messengers and effector mechanisms. Stimuli other than ischaemia, such as hypoxic perfusion, tachycardia and pharmacological agents, including isoflurane, have preconditioning-like effects. Currently ischaemic preconditioning is used during minimally invasive cardiac surgery without cardiopulmonary bypass to protect the myocardium against ischaemic injury during the anastomosis.
CONCLUSION: Ischaemic preconditioning is a powerful protective mechanism against ischaemic injury in many organ systems. Future clinical applications will depend on the clarification of the underlying biochemical mechanisms, the development of pharmacological methods to induce preconditioning, and controlled trials in humans showing improved outcomes.

Entities:  

Mesh:

Year:  1998        PMID: 9717602     DOI: 10.1007/BF03012100

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

Review 1.  Current protective strategies in liver surgery.

Authors:  Kurinchi S Gurusamy; Hector D Gonzalez; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Hypoxic preconditioning: a novel intrinsic cytoprotective strategy.

Authors:  Guo-Wei Lu; Shun Yu; Rao-Hua Li; Xiu-Yu Cui; Cui-Ying Gao
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Effects of hypoxic preconditioning on the hypoxic-reoxygenated atria from fed and fasted rats.

Authors:  G Testoni; S Cerruti; P Kade; M Carregal; A Varela; E A Savino
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

Review 4.  Hypoxic preconditioning protects against ischemic brain injury.

Authors:  Frank R Sharp; Ruiqiong Ran; Aigang Lu; Yang Tang; Kenneth I Strauss; Todd Glass; Tim Ardizzone; Myriam Bernaudin
Journal:  NeuroRx       Date:  2004-01

5.  Pre-conditioning with low-level laser (light) therapy: light before the storm.

Authors:  Tanupriya Agrawal; Gaurav K Gupta; Vikrant Rai; James D Carroll; Michael R Hamblin
Journal:  Dose Response       Date:  2014-09-22       Impact factor: 2.658

6.  Effects of fasting and hypoxic preconditioning on the hypoxic-reoxygenated ventricular strips of the rat heart.

Authors:  S Cerruti; G Testoni; V Dalamon; P Kade; A Varela; E A Savino
Journal:  J Physiol Biochem       Date:  2002-06       Impact factor: 4.158

7.  The influence of preconditioning on metabolic changes in the pig liver before, during, and after warm liver ischemia measured by microdialysis.

Authors:  Anne-Sofie Kannerup; Henning Grønbæk; Peter Funch-Jensen; Rasmus Langelund Jørgensen; Frank Viborg Mortensen
Journal:  Hepatol Int       Date:  2008-10-15       Impact factor: 6.047

8.  No renal protection from volatile-anesthetic preconditioning in open heart surgery.

Authors:  Wacharin Sindhvananda; Krit Phisaiphun; Prut Prapongsena
Journal:  J Anesth       Date:  2012-08-12       Impact factor: 2.078

9.  Potential Benefits of Peroxynitrite.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Open Pharmacol J       Date:  2008

10.  Chronic lower extremity ischemia: a human model of ischemic tolerance.

Authors:  Amit Badhwar; Thomas L Forbes; Marge B Lovell; Alison A Dungey; Sarah D McCarter; Jeffrey R Scott; Guy DeRose; Kenneth A Harris; Richard F Potter
Journal:  Can J Surg       Date:  2004-10       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.